The Impact of New Immunological Therapeutic Strategies on Recurrent Miscarriage and Recurrent Implantation Failure

•Maternal-fetal immune dysregulation is one of the risk factors that increases the probability of reproductive failure.•Maternal tolerance toward fetal alloantigens is required to prevent this semi-allograft rejection.•Immunotherapy and cell therapy methods possess the ability to manage reproductive...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Immunology letters 2021-08, Vol.236, p.20-30
Hauptverfasser:	Parhizkar, Forough, Motavalli-Khiavi, Roza, Aghebati-Maleki, Leili, Parhizkar, Zahra, Pourakbari, Ramin, Kafil, Hossein Samadi, Danaii, Shahla, Yousefi, Mehdi
Format:	Artikel
Sprache:	eng
Schlagworte:	Abortion, Habitual - etiology Abortion, Habitual - therapy Biomarkers Cell therapy Cell- and Tissue-Based Therapy - methods Combined Modality Therapy Disease Management Disease Susceptibility - immunology Embryo Implantation Female Humans Immunoglobulins, Intravenous - pharmacology Immunoglobulins, Intravenous - therapeutic use Immunologic Factors - pharmacology Immunologic Factors - therapeutic use Immunomodulation Immunosuppressive Agents - pharmacology Immunosuppressive Agents - therapeutic use Immunotherapy Immunotherapy - methods Pregnancy Pregnancy Outcome Recurrent Implantation Failure Recurrent miscarriage Recurrent pregnancy loss Signal Transduction - drug effects Stem Cell Transplantation - methods Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!